Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elucid mHealth is a private UK digital health and medtech company focused on medication adherence monitoring for clinical trials and launched drug programs. Its core offering, Pill Connect, is a connected smart pill dispenser and software platform that captures time-stamped dosing events, supports remote monitoring, and helps sponsors, CROs, and study teams track adherence and engagement in real time. The company positions its technology as a way to improve protocol compliance, reduce reliance on self-reported adherence, and support decentralized or hybrid trial designs. Elucid mHealth appears to operate as a commercial-stage healthcare technology company rather than a therapeutics developer, with value centered on trial operations, adherence analytics, and connected drug accountability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elucid mHealth.